Baltic Atherosclerosis Conference 2021

03.12.2021 - 04.12.2021  Tallinn, Estonia

Updated CV prevention in the ESC 2021 CVD Prevention guidelines

Prof. Rimvydas Šlapikas (Lithuania)
Professor of medicine, Cardiologist, Department of Coronary Artery Disease, Hospital of Lithuanian University of Health Sciences
Biography: Prof. Rimvydas Šlapikas main research areas are dyslipidaemia, hypertension and cardiovascular disease prevention. The current field of his scientific research and interest is the assessment of the predictive value of novel biochemical markers and subclinical atherosclerosis in asymptomatic high-risk patients for future coronary events, targeting patients with the metabolic syndrome and severe familial hypercholesterolemia. He is an author and co-author of more than 100 scientific publications in national and international journals. Rimvydas Slapikas was acting as investigator, principle investigator or national coordinator in over 50 clinical trials.
Professor Rimvydas Slapikas is President of Lithuanian Society of Cardiology and the National Coordinator for ESC guidelines and cardiovascular prevention in Lithuania. He has been an invited speaker and chairman in many international meetings including European Meetings on Hypertension and Dyslipidaemia, Nordic-Baltic Congresses of Cardiology, Baltic Atherosclerosis Congresses.

Small Hall

17:05 - 17:35

Media:

  • view the video of this presentation
  • This agenda item is presented in the following session: S5 - Atherosclerosis and ESC 2021 CVD Prevention guidelines

    Plenary session

    03.12.2021 17:05 - 17:45